Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study

A González-Martín; B Pothuri; I Vergote; RD Christensen; W Graybill; MR Mirza; C McCormick; D Lorusso; P Hoskins; G Freyer; K Baumann; K Jardon; A Redondo; RG Moore; C Vulsteke; RE O’Cearbhaill; B Lund; F Backes; P Barretina-Ginesta; AF Haggerty; MJ Rubio-Pérez; MS Shahin; G Mangili; WH Bradley; I Bruchim; K Sun; I Malinowska; Y Li; D Gupta; BJ Monk

doi:10.1136/ijgc-2019-ESGO.9

Article info

Best Oral Communications/Late-Breaking Abstracts 3 – Ovarian Cancer

Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study

Authors

A González-Martín Grupo Español de Investigación en Cáncer de Ovario (GEICO) and Medical Oncology Department, Clínica Universidad de Navarra, Madrid, Spain PubMed articles Google scholar articles
B Pothuri Gynecologic Oncology Group (GOG) and Department of Obstetrics/Gynecology, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA PubMed articles Google scholar articles
I Vergote Belgium and Luxembourg Gynaecological Oncology Group (BGOG) and Department of Gynaecology and Obstetrics, Division of Gynaecological Oncology, University Hospitals Leuven, Leuven Cancer Institute, Leuven, Belgium PubMed articles Google scholar articles
RD Christensen Nordic Society of Gynaecological Oncology (NSGO) and Research Unit of General Practice, Institute of Public Health, University of Southern Denmark, Odense, Denmark PubMed articles Google scholar articles
W Graybill GOG and Gynecologic Oncology, Medical University of South Carolina, Charleston, SC, USA PubMed articles Google scholar articles
MR Mirza NSGO and Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark PubMed articles Google scholar articles
C McCormick GOG and Legacy Medical Group Gynecologic Oncology, Portland, OR, USA PubMed articles Google scholar articles
D Lorusso Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies (MITO) and Fondazione IRCCS National Cancer Institute of Milan, Milan, Italy PubMed articles Google scholar articles
P Hoskins US Oncology Research (USOR) and Department of Medical Oncology, BC Cancer – Vancouver, Vancouver, BC, Canada PubMed articles Google scholar articles
G Freyer Groupe d’Investigateurs Nationaux pour l’Etude des Cancers Ovariens (GINECO) and Service d’Oncologie Médicale, Centre Hospitalier Lyon-Sud, Lyon, France PubMed articles Google scholar articles
K Baumann Arbeitsgemeinschaft Gynäkologische Onkologie (AGO) and Department of Gynecology and Obstetrics, Klinikum der Stadt Ludwigshafen, Ludwigshafen, Germany PubMed articles Google scholar articles
K Jardon GOG and Department of Obstetrics and Gynecology, McGill University, Department of Oncology, McGill University Health Centre, Division of Gynecologic Oncology, Montreal, QC, Canada PubMed articles Google scholar articles
A Redondo GEICO and Hospital Universitario La Paz-IdiPAZ, Madrid, Spain PubMed articles Google scholar articles
RG Moore USOR and Division of Gynecologic Oncology, Wilmot Cancer Institute, Department of Obstetrics and Gynecology, University of Rochester, Rochester, NY, USA PubMed articles Google scholar articles
C Vulsteke BGOG and Department of Medical Oncology and Hematology, AZ Maria Middelares, Gent, and Department of Molecular Imaging, Pathology, Radiotherapy and Oncology, Center for Oncological Research, Antwerp University, Antwerp, Belgium PubMed articles Google scholar articles
RE O’Cearbhaill GOG and Department of Medicine, Memorial Sloan Kettering Cancer Center, Department of Medicine, Weill Cornell Medical College, New York, NY, USA PubMed articles Google scholar articles
B Lund NSGO and Department of Oncology, Aalborg University, Aalborg, Denmark PubMed articles Google scholar articles
F Backes Division of Gynecologic Oncology, Ohio State University, Columbus, OH, USA PubMed articles Google scholar articles
P Barretina-Ginesta GEICO and Medical Oncology Department, Catalan Institute of Oncology (ICO) – Hospital Universitari Dr Josep Trueta, and Department of Medical Sciences, Medical School University of Girona, Girona, Spain PubMed articles Google scholar articles
AF Haggerty GOG and Division of Gynecologic Oncology, University of Pennsylvania, Philadelphia, PA, USA PubMed articles Google scholar articles
MJ Rubio-Pérez GEICO and Hospital Universitario Reina Sofía, Cordoba, Spain PubMed articles Google scholar articles
MS Shahin GOG and Hanjani Institute for Gynecologic Oncology, Asplundh Cancer Pavilion, Abington Jefferson Hospital, Sidney Kimmel Medical College of Thomas Jefferson University, Willow Grove, PA, USA PubMed articles Google scholar articles
G Mangili MITO and Department of Obstetrics and Gynaecology, San Raffaele Scientific Institute, Milan, Italy PubMed articles Google scholar articles
WH Bradley GOG and Department of Obstetrics and Gynecology, Medical College of Wisconsin, Milwaukee, WI, USA PubMed articles Google scholar articles
I Bruchim Israeli Society of Gynecologic Oncology (ISGO) and Department of Gynecology and Gynecologic Oncology, Hillel Yaffe Medical Center, Technion Israel Institute of Technology, Haifa, Israel PubMed articles Google scholar articles
K Sun TESARO: A GSK Company, Waltham, MA PubMed articles Google scholar articles
I Malinowska TESARO: A GSK Company, Waltham, MA PubMed articles Google scholar articles
Y Li TESARO: A GSK Company, Waltham, MA PubMed articles Google scholar articles
D Gupta TESARO: A GSK Company, Waltham, MA PubMed articles Google scholar articles
BJ Monk Arizona Oncology (US Oncology Network), University of Arizona College of Medicine, Creighton University School of Medicine, Phoenix, AZ, USA PubMed articles Google scholar articles

Citation

González-Martín A, Pothuri B, Vergote I, et al

Niraparib therapy in patients with newly diagnosed advanced ovarian cancer after chemotherapy: PRIMA/ENGOT-OV26/GOG-3012 study

International Journal of Gynecologic Cancer 2019;29:A9-A10.

Publication history

First published November 1, 2019.

Online issue publication

March 03, 2020

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password